fatty liver - HealthQuill

Novo Nordisk will acquire US-based Akero Therapeutics, Inc. for $5.2 billion to pocket an experimental drug in end-stage trials to treat liver disease, the company announced.

Novo to buy Akero for $5.2 billion, to pocket trial liver disease drug

Novo Nordisk will acquire US-based Akero Therapeutics, Inc. for $5.2 billion to pocket an experimental drug in end-stage trials to treat liver disease,.

by HealthQuill
October 9, 2025
0 Comments

Swiss healthcare multinational F. Hoffmann-La Roche AG will acquire US-based 89bio Inc. for a deal worth up to $3.5 billion to expand its metabolic disease portfolio.

Drugs Health Pharma

Roche to buy 89bio Inc for $3.5 billion to expand metabolic disease portfolio

Swiss healthcare multinational F. Hoffmann-La Roche AG will acquire US-based 89bio Inc. for a deal worth up to $3.5 billion to expand its.

by HealthQuill
September 18, 2025
0 Comments

Consumption of fast food may lead to nonalcoholic fatty liver disease, a life-threatening condition, according to researchers from the Keck School of Medicine of the University of Southern California.

Health Pharma

Fast food may cause nonalcoholic fatty liver disease: Keck Medicine

Consumption of fast food may lead to nonalcoholic fatty liver disease, a life-threatening condition, according to researchers from the Keck School of Medicine.